CN113271849B - 结合类别不平衡集降采样与生存分析的疾病风险确定方法 - Google Patents

结合类别不平衡集降采样与生存分析的疾病风险确定方法 Download PDF

Info

Publication number
CN113271849B
CN113271849B CN201980078901.3A CN201980078901A CN113271849B CN 113271849 B CN113271849 B CN 113271849B CN 201980078901 A CN201980078901 A CN 201980078901A CN 113271849 B CN113271849 B CN 113271849B
Authority
CN
China
Prior art keywords
class
fold
data
imbalanced
dataset
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201980078901.3A
Other languages
English (en)
Chinese (zh)
Other versions
CN113271849A (zh
Inventor
Y·夏甲
G·达塔
L·亚历山大
M·欣特伯格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Private Placement Protein Body Operation Co ltd
Original Assignee
Private Placement Protein Body Operation Co ltd
SomaLogic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Private Placement Protein Body Operation Co ltd, SomaLogic Inc filed Critical Private Placement Protein Body Operation Co ltd
Publication of CN113271849A publication Critical patent/CN113271849A/zh
Application granted granted Critical
Publication of CN113271849B publication Critical patent/CN113271849B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/021—Measuring pressure in heart or blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/103—Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/117—Identification of persons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4866—Evaluating metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4869—Determining body composition
    • A61B5/4872—Body fat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7221—Determining signal validity, reliability or quality
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • G—PHYSICS
    • G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
    • G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Artificial Intelligence (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Signal Processing (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dentistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Cardiology (AREA)
  • Mathematical Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Evolutionary Computation (AREA)
  • Fuzzy Systems (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Mathematical Analysis (AREA)
  • Computational Mathematics (AREA)
  • Algebra (AREA)
  • Mathematical Optimization (AREA)
CN201980078901.3A 2018-11-29 2019-11-21 结合类别不平衡集降采样与生存分析的疾病风险确定方法 Active CN113271849B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862773028P 2018-11-29 2018-11-29
US62/773,028 2018-11-29
US201862783733P 2018-12-21 2018-12-21
US62/783,733 2018-12-21
PCT/US2019/062561 WO2020112478A1 (en) 2018-11-29 2019-11-21 Methods for determining disease risk combining downsampling of class-imbalanced sets with survival analysis

Publications (2)

Publication Number Publication Date
CN113271849A CN113271849A (zh) 2021-08-17
CN113271849B true CN113271849B (zh) 2024-08-30

Family

ID=70852605

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980078901.3A Active CN113271849B (zh) 2018-11-29 2019-11-21 结合类别不平衡集降采样与生存分析的疾病风险确定方法

Country Status (10)

Country Link
US (1) US20220015714A1 (cg-RX-API-DMAC7.html)
EP (1) EP3886696A4 (cg-RX-API-DMAC7.html)
JP (2) JP7680950B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210099605A (cg-RX-API-DMAC7.html)
CN (1) CN113271849B (cg-RX-API-DMAC7.html)
AU (1) AU2019385818B2 (cg-RX-API-DMAC7.html)
CA (1) CA3120716A1 (cg-RX-API-DMAC7.html)
IL (1) IL283467A (cg-RX-API-DMAC7.html)
SG (1) SG11202105063QA (cg-RX-API-DMAC7.html)
WO (1) WO2020112478A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11996201B2 (en) * 2021-03-04 2024-05-28 Abbott Laboratories Technology to automatically identify the most relevant health failure risk factors
JP7322918B2 (ja) * 2021-03-29 2023-08-08 横河電機株式会社 プログラム、情報処理装置、及び学習モデルの生成方法
KR102393367B1 (ko) 2021-11-15 2022-05-03 오브젠 주식회사 생존 분석 시스템 및 그 제어방법
KR102424884B1 (ko) 2021-11-18 2022-07-27 오브젠 주식회사 생존 데이터 정제 서버와 생존 데이터 분석 서버를 포함하는 시스템 및 그 제어방법
CN114548327A (zh) * 2022-04-27 2022-05-27 湖南工商大学 基于平衡子集的软件缺陷预测方法、系统、设备及介质
CN115114270B (zh) * 2022-06-14 2024-08-02 马上消费金融股份有限公司 数据降采样方法及装置、电子设备、计算机可读存储介质
KR102688743B1 (ko) * 2023-08-16 2024-07-26 렉스이노베이션 주식회사 분산 배터리의 soh에 기초하여 이상을 탐지하는 방법
US20250069754A1 (en) * 2023-08-22 2025-02-27 Elythea, Inc. Predicting risk of pregnancy-related complications using machine learning
CN121015165A (zh) * 2025-06-30 2025-11-28 延边大学 基于多模态特征融合的睡眠呼吸暂停识别方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7982066B2 (en) * 2005-12-09 2011-07-19 Novalife, Inc. High protein supplement
US7947447B2 (en) 2007-01-16 2011-05-24 Somalogic, Inc. Method for generating aptamers with improved off-rates
AU2010328019A1 (en) * 2009-12-09 2012-06-28 Aviir, Inc. Biomarker assay for diagnosis and classification of cardiovascular disease
US20120271553A1 (en) * 2011-04-22 2012-10-25 Ge Global Research Analyzing the expression of biomarkers in cells with clusters
WO2018048960A1 (en) 2016-09-07 2018-03-15 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
CN104573708A (zh) * 2014-12-19 2015-04-29 天津大学 组合降采样极限学习机
EP3356560A4 (en) * 2015-09-30 2019-06-12 Inform Genomics, Inc. SYSTEMS AND METHODS FOR PREDICTING EVENTS RELATED TO A THERAPEUTIC REGIME
WO2017214397A1 (en) 2016-06-08 2017-12-14 University Of Iowa Research Foundation Compositions and methods for detecting predisposition to cardiovascular disease
GB201614394D0 (en) * 2016-08-23 2016-10-05 Imp Innovations Ltd Method
CA3052349C (en) 2017-02-02 2024-06-04 B.R.A.H.M.S Gmbh Proadm as marker indicating an adverse event
AU2018100796A4 (en) * 2018-06-14 2018-07-19 Macau University Of Science And Technology A genetic feature identifying system and a search method for identifying features of genetic information

Also Published As

Publication number Publication date
WO2020112478A1 (en) 2020-06-04
EP3886696A4 (en) 2022-08-24
KR20210099605A (ko) 2021-08-12
JP2022509835A (ja) 2022-01-24
US20220015714A1 (en) 2022-01-20
AU2019385818B2 (en) 2025-04-24
IL283467A (en) 2021-07-29
JP7680950B2 (ja) 2025-05-21
EP3886696A1 (en) 2021-10-06
AU2019385818A1 (en) 2021-07-08
CA3120716A1 (en) 2020-06-04
SG11202105063QA (en) 2021-06-29
JP2025061136A (ja) 2025-04-10
CN113271849A (zh) 2021-08-17

Similar Documents

Publication Publication Date Title
JP7680950B2 (ja) 生存分析によるクラス不均衡セットのダウンサンプリングを組み合わせた疾患リスクを判定するための方法
Pedersen et al. cyCombine allows for robust integration of single-cell cytometry datasets within and across technologies
Kukar et al. COVID-19 diagnosis by routine blood tests using machine learning
Spann et al. Applying machine learning in liver disease and transplantation: a comprehensive review
Sweeney et al. A community approach to mortality prediction in sepsis via gene expression analysis
Maan et al. Characterizing the impacts of dataset imbalance on single-cell data integration
EP2016405B1 (en) Methods and apparatus for identifying disease status using biomarkers
Tomás et al. A general method to derive robust organ-specific gene expression-based differentiation indices: application to thyroid cancer diagnostic
RU2640568C2 (ru) Способы и системы для оценки риска рака желудочно-кишечного тракта
US20130103321A1 (en) Selection of Preferred Sample Handling and Processing Protocol for Identification of Disease Biomarkers and Sample Quality Assessment
Zheng et al. Prospective accuracy for longitudinal markers
US20250059511A1 (en) Systems and methods for associating compounds with physiological conditions using fingerprint analysis
CN105229471A (zh) 用于基于生物化学标记分析确定先兆子痫风险的系统和方法
US20220084639A1 (en) Electronic Phenotyping Technique for Diagnosing Chronic Kidney Disease
CN118629517B (zh) 用于新冠病毒易感性的预测标志物以及预测方法、装置
JP2026511166A (ja) 1つ以上の予測バイオマーカを同定するための人工知能
HK40059456A (en) Methods for determining disease risk combining downsampling of class-imbalanced sets with survival analysis
Kalani et al. Prognostic value of intensive care scores concerning the prediction of 30-day mortality in COVID-19
HK40059456B (en) Methods for determining disease risk combining downsampling of class-imbalanced sets with survival analysis
Lin et al. Monocyte distribution width enhances the detection of infection in patients after primary percutaneous coronary intervention
Lyu et al. Protocol for classification single-cell PBMC types from pathological samples using supervised machine learning
Li et al. STE-Model: Stack-Vote Ensemble Model for Predicting 30-Day Mortality in Sepsis Patients
CN121874354A (zh) 一种精准定量检测细胞产品中凋亡细胞的方法
CN120035864A (zh) 用于验证蛋白质组学模型的系统和方法
HK40130671A (en) Artificial intelligence for identifying one or more predictive biomarkers

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20220308

Address after: Colorado, USA

Applicant after: Private placement protein body Operation Co.,Ltd.

Address before: Colorado, USA

Applicant before: SOMALOGIC, Inc.

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40059456

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant